Canada markets closed
  • S&P/TSX

    19,040.78
    -163.64 (-0.85%)
     
  • S&P 500

    4,134.94
    -28.32 (-0.68%)
     
  • DOW

    33,821.30
    -256.33 (-0.75%)
     
  • CAD/USD

    0.7928
    -0.0006 (-0.07%)
     
  • CRUDE OIL

    62.61
    +0.17 (+0.27%)
     
  • BTC-CAD

    71,292.45
    +226.53 (+0.32%)
     
  • CMC Crypto 200

    1,296.41
    +62.00 (+5.02%)
     
  • GOLD FUTURES

    1,778.10
    -0.30 (-0.02%)
     
  • RUSSELL 2000

    2,188.21
    -43.79 (-1.96%)
     
  • 10-Yr Bond

    1.5620
    -0.0390 (-2.44%)
     
  • NASDAQ futures

    13,747.00
    -47.25 (-0.34%)
     
  • VOLATILITY

    18.68
    +1.39 (+8.04%)
     
  • FTSE

    6,859.87
    -140.21 (-2.00%)
     
  • NIKKEI 225

    29,100.38
    -584.99 (-1.97%)
     
  • CAD/EUR

    0.6585
    -0.0002 (-0.03%)
     

Brazil's Hapvida, Intermedica detail share swap in $9 bln hospital tie-up

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

RIO DE JANEIRO, Feb 28 (Reuters) - Brazilian insurer and hospital operator Hapvida Participacoes e Investimentos SA and competitor Notre Dame Intermedica Participacoes SA disclosed the share conversion terms of a previously announced tie-up that would create the country's largest hospital chain.

The companies said that Intermedica shares will be incorporated into Hapvida, with one Intermedica share being swapped for 5.249 Hapvida shares and an additional 6.45 reais, according to a pair of Saturday night securities filings.

Hapvida shareholders will own 53.6% of the combined company after the deal.

The chief executives of both companies will be active of the board of directors of the combined company, the securities filings said.

The transaction costs will likely come to 116 million reais ($20.7 million), the companies said.

In January, Hapvida offered 49 billion reais ($8.75 billion) to purchase Intermedica. The combined company will have 8.4 million healthcare clients and 70 hospital spread throughout the country.

The final deal is still subject to the approval of the companies' shareholders, as well as health and antitrust authorities in Brazil.

($1 = 5.60 reais)

(Reporting by Gram Slattery; Editing by Lisa Shumaker)